To study whether these factors impact B7H3.CAR EBVSTs long-term persistence and activity, we subjected B7H3.CAR EBVST-treated mice to a tumor rechallenge and observed that B7H3.CAR EBVSTs maintained robust activity and persistence by rejecting NCI-N87 tumors. Here, CD276 is linked to neoplasm.